Xylem (XYL) Stock Forecast & Price Target
$20.82B
Market Cap
20.54
P/E
15.98
Forward P/E
58
Score
XYL price $89.19 +0.96 +1.09%
Stocklytics score rationale: value 64, quality 52, growth 59.
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 3771000000 | 4707000000 | 5207000000 | 5249000000 | 4876000000 | 5195000000 | 5522000000 | 7364000000 | 8562000000 | 9035000000 |
Xylem Inc., together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions for utility, industrial, and residential and commercial building services settings worldwide. It operates through Water Infrastructure; Applied Water; Measurement and Control Solutions; and Water Solutions and Services segments. The company offers water, wastewater, and storm water pumps…
Consensus Buy from 21 analysts. Average price target $144.25, +61.7% versus the current price. Low $112.00. High $165.00.
Insights · Dividends · Forecast · Financials · Learn
Analysts have an average 12-month price target of $144.25 for Xylem (XYL), 61.7% above the current price of $89.19. Of 21 analysts covering the stock, 14 rate it Buy or Strong Buy, 7 Hold, and 0 Sell or Strong Sell, giving a consensus of Buy.
Forecasts are third-party estimates and often wrong. They are not investment advice.
| Low | $112.00 |
|---|---|
| Average | $144.25 |
| High | $165.00 |
The average is 61.7% above the current price of $89.19.
Of 21 analysts, 14 rate Xylem Buy or Strong Buy, 7 Hold, and 0 Sell or Strong Sell. The consensus label is Buy. That split is not a recommendation.
Analyst averages on file: 2026, EPS $5.58, revenue $9.10 billion. 2027, EPS $6.08, revenue $9.48 billion.
The Stocklytics Score for XYL is 58 out of 100. It averages value, quality, and growth against a large-cap US universe. It is not a price target and not a buy or sell rating. Fair value is a separate estimate on the fair value tab.
$144.25 average, with a published range of $112.00 to $165.00.
The consensus is Buy from 21 analysts. This is not a recommendation.
Analysts' average EPS estimate for 2026 on file is $5.58. The average revenue estimate is $9.10 billion.
No reliable forecast exists that far out.
The next earnings date is shown on the stock page when a future report is on the calendar. This forecast does not invent a date.
Related: Xylem · Financials · Dividends · Compare · AI stocks
Capital is at risk. Stocklytics is operated by Stocklytics Inc., a Marshall Islands company. It is not regulated by the FCA and does not give investment advice.
$20.82B
Market Cap
20.54
P/E
15.98
Forward P/E
58
Score